This website uses cookies to ensure that we give you the best experience and offer services that are relevant to you. If you close this banner, scroll down or click anywhere on this page, you are giving consent to cookies being used. If you want to know more about cookies or disable some or all of them please read the Privacy Policy.

Enzaver

Specifications

Active substance	Cinnarizine 20 mg/Dimenhydrinate 40 mg
Package	Enzaver 20 mg/40 mg tablets - 20 tablets in Pvc/Pvdc/Al/Pvdc blister packs (AIC no. 044184012)
Class	Class C / RR
Public Price	€ 13,50
VAT	10%
Therapeutic indications	Treatment of vertiginous symptoms of various origins. Enzaver is indicated in adults.
Posology	Read SmPC
Manufacturing Facility	-
Date of marketing	February 2021
Patent Status	Unprotected
Owner	Granted on a distribution agreement to Ecupharma S.r.l. Via Mazzini 20 20123 Milan (Italy) by Tecnigen S.r.l. Via Galileo Galilei, 40 20092 Cinisello Balsamo (MI)
Read SmPC	rcp_enzaver-211804046.pdf

Sede legale: Via Mazzini 20, 20123 Milano
Uffici operativi: Via Newton 9/A, 20016 Pero MI

+39 02 38238790

info@ecupharma.it

Ecupharma Srl.

C. Fiscale e Partita IVA 10863670153
Tribunale di Milano Reg. Soc. N. 10863670153
CCIAA Milano N. 1412760
Capitale Sociale € 65.572,00 int. vers.

Disclaimer | Privacy Policy